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Dr Anthony L. Estrera (Houston, Tex). I have nothing to
disclose.
Since Dr Griepp’s seminal report on the use of PHCA for total
arch replacement, many adjuncts have been devised for use in
combination for cerebral protection. Ueda with RCP and Bachet
and Kazui with ACP were early proponents.
Currently, most large aortic centers have reported the use of
ACP as the primary mode of cerebral perfusion during hypother-
mic circulatory arrest, suggesting that the use of RCP has for the
most part been abandoned.
The findings from the present report by Girardi and colleagues,
in which RCP was used as the primary adjunct for cerebral perfu-
sion during ascending and arch replacement, resulting in very envi-
able outcomes, stroke of 2%, mortality of 4%, including those with
type A dissection, suggest that RCP could still play a pertinent
role.
Despite my enthusiasm for RCP during circulatory arrest, I
must be candid and discerning of this report by Girardi and col-
leagues. As acknowledged by the authors, the study was a retro-
spective analysis with its inherent limitations, occurring during a
15-year period and, thus, potentially biased by the changes that
could have occurred over time.
The study design was more observational than comparative,
because no true control group was designated. Because it was a
single-center and single-surgeon study, the results should not
necessarily be generalized. Despite these issues, it was a very large
series that provides value in the questions that arise from such a
study.
I have a few questions that can be answered consecutively.
First, the atheromatous burden remains a significant risk factor
for stroke after cardiovascular surgery. Do you have any informa-
tion on the degree of aortic atheromatous disease, and can you
please comment on your interrogation methods before cannulating
the ascending aorta?
Dr Girardi. Yes, and thank you very much, Dr Estrera.
So, before surgery, all our patients underwent transesophageal
echocardiography. In those patients who were deemed to have
grade 4 or 5 disease, we then tried to use epiaortic scanning. We
also used epiaortic echocardiography if we had found palpably sig-
nificant calcium in the ascending aorta or arch in the area in which
we were anticipating cannulation.
Also, in those patients with a very hostile ascending aorta, we
will switch to femoral access, which does not adversely affect
our stroke risk. Obviously, computed tomography or magnetic
resonance imaging will provide us with some idea of what is pre-
sent in the descending aorta, and we can also see that with trans-
esophageal echocardiography.diovascular Surgery c Volume 148, Number 6 2933
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perature management during repair? How was your temperature
measured? What determined how long you cool? I noticed it
was about 33 minutes as the mean cooling time.
Dr Girardi. We have avoided electroencephalographic moni-
toring while cooling. It was just a logistical problem for us. We
used it early in our experience and found that if wewent to electroen-
cephalographic silence, it did not necessarily eliminate ourneurologic
problems, especially with TND. Not so much permanent deficits, but
TND was still a problem if we cooled for<25 minutes or so.
We set a minimum of 30 minutes as our mark. We used the
bladder temperature as our cooling monitor. If the patient was
anuric from end-stage renal disease, we used a tympanic probe.
We have not found anything else to be terribly reliable.
Dr Estrera. Third, please elaborate on your neuromonitoring
approach. Do the near-infrared spectroscopy (NIRS) findings
change what you do? Do you modify your RCP perfusion pres-
sures during circulatory arrest if you do see changes?
Dr Girardi. Yes. We have used NIRS mostly to monitor perfu-
sion when we return to CPB. For the patients with acute type A
dissection, we use it when we first start CPB, because certainly ce-
rebral malperfusion can happen when you are using femoral can-
nulation. We have seen it once or twice, and that has, on an
emergency basis, changed our method of perfusion.
We also use it when we return to CPB after circulatory arrest,
because we want to ensure that we have been perfusing both hemi-
spheres equally. Also, I think it is very sensitive for showing that.
Regarding the trends with the patient under circulatory arrest,
we have seen most of the time that the NIRS is around 60 or 70.
Occasionally, after 40, 50minutes, it might decrease 5 or 10 points,
but not more than that.
When you consider the general population of patients undergo-
ing CPB, NIRSmonitoring is not particularly sensitive at detecting
a real problem until the finding is less than about 30%, which we
rarely, if ever, see.
Dr Estrera. Finally, as many would have me believe, is RCP
dead?
Dr Girardi. I do not think RCP is dead, and I know a few of us
out there are still using it. I understand the concerns for it, but I
think, as you can see fromDr Elefteriades’ presentation, I think hy-
pothermia is the key element of brain protection. Whether you add
on RCP or ACP in addition to cold or just use straight profound hy-
pothermia, I think you achieve pretty good protection, particularly
with short periods of circulatory arrest.
Also, I think what we are all looking for is what to do with these
really complex patients out in that 50- to 60-minute range. Our
data would suggest that RCP is safe in that patient population.
Of course, as you noted the limitations of the study, it was retro-
spective and a single-institution, single-surgeon experience.
However, for the overwhelming majority undergoing arch sur-
gery, I think RCP works pretty well.
Dr Yutaka Okita (Kobe, Japan). Recently, we collected Japa-
nese data for 4 years, 8000 cases of total arch replacement, and
1000 received RCP and 7000, ACP.
Virtually RCP people tend to do arch first techniques. It is very
short even in total arch replacements.
We found virtually no difference in stroke, TND, or early mortal-
ity. However, we found the RCP patients tended to wake up late and2934 The Journal of Thoracic and Cardiovascular Surstay in the intensive care unit longer.Also,ACPpatientsusuallywoke
upon thedayof the operation.TheRCPpatientswokeup thenext day
and they extubated late. Did you consider this wake-up time?
DrGirardi.Wedid not study thewake-up time per se; however,
our transient neurologic deficit rate included those patients who
had temporary defects that did not allow them to wake up imme-
diately. Again, confusion, delirium, items along those lines, are
difficult to quantify; however, we included all those into our
TND experience.
The experience in 2 large meta-analyses with>5000 patients in
each study showed very little difference between the results with
the ACP or RCP. However, meta-analyses have a number of limi-
tations and the data have not convinced me regarding the safety of
ACP, either unilateral or bilateral, compared with RCP.
Dr Joseph S. Coselli (Houston, Tex).Len, I am going to jump in
with 1 quick question. Returning even to the experience that you
referenced with Dr Crawford, when we used a very similar tech-
nique to what you described, we encountered a peculiar phenom-
enon frequently referred to as ‘‘supranuclear hemianopsia,’’ which
manifested primarily by a disconjugate gaze. However, in the
many hundreds of cases, since we have switched to ACP, although
it is a rare complication, we just have not seen it anymore. You
have a very, very large series. Any experience with that?
Dr Girardi. Thank you Joe. I am familiar with that problem but
we did not see that at all, not 1 time.
Dr John A. Elefteriades (New Haven, Conn). First, congratu-
lations on the fantastic results and a beautiful report.
My short question is, is it possible that the RCP is ‘‘just along
for the ride’’?
Dr Girardi. It is possible. I think, just as your group has so
eloquently shown, 40 minutes with straight hypothermic arrest,
things are pretty safe.
I agree with your group that profound hypothermia is the key.
Cold has gotten a really bad reputation as you can see with some
of the ACP reports that are now espousing moderate hypothermia.
Forgive me, I know Dr Coselli’s group recently published on this
and showed very good results withmoderate hypothermia. Howev-
er, I have a number of concerns about that technique, not only for
brain protection, but also for end organ protection, including the
kidneys, spinal cord, and gut.
Also, I realize that a number of centers using it on a regular basis
have become pretty comfortablewith it. However, I do not think that
profound hypothermia carries with it the bleeding risks that con-
cerned surgeons in the past. I think if you really take the time to rein-
force your suture lines and achieve surgical hemostasis before
returning the patient to CPB, bleeding will not be a great risk.
So, I like cold. We like cold. Also, I think up to about 40 mi-
nutes, the use of adjunct therapy might not add a lot.
Dr Eric E. Roselli (Cleveland, Ohio). Len, I echo the congrat-
ulations from everyone else. Outstanding acute results.
These patients who have disease encroaching on their arch or
involving their arch obviously have an entire aorta that is diseased,
and what I am concerned about is that at 10 years, we only saw sur-
vival of around 60%.
Can you tell us whether you have any information about the
modes of death of these patients, and tell us what you do to
follow-up these patients. Do you continue to monitor them long
term with imaging of their aortas?gery c December 2014
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follow-up patients with imaging for as long as they will continue
to come for their imaging studies or go to their local place for im-
aging studies and send them to us.
For those patients for whom we were unable to get
adequate follow-up data at our institution, we would call
the referring physicians, the family, and the Social SecurityThe Journal of Thoracic and CarDeath Index to confirm death. However, we were unable to
determine the modes of death exactly for many of these
patients.
Regarding the need for reintervention on our arch patients, we
had a very low rate of reintervention. It was somewhat<5% out
to 5 to 7 years. We have not published those data yet, but we are
compiling the data.diovascular Surgery c Volume 148, Number 6 2935
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